Certificate Programme in Drug Repurposing for Pediatric Conditions
Published on June 28, 2025
About this Podcast
HOST: Welcome to our podcast, today I'm thrilled to have Dr. Jane Smith with us, an expert in pediatric drug development and the lead instructor for the Certificate Programme in Drug Repurposing for Pediatric Conditions. Dr. Smith, can you tell us a bit about what inspired you to create this course? GUEST: Absolutely, I've seen a growing need for professionals who understand the unique challenges of pediatric drug development, and drug repurposing is a promising approach to address unmet medical needs in children. HOST: That's fascinating. Can you share any current trends in the industry related to drug repurposing for pediatric conditions? GUEST: Certainly, there's increasing interest in leveraging real-world data and adaptive trial designs to accelerate the drug repurposing process for children. HOST: Those sound like exciting advancements. I imagine there must be challenges in this field; could you share any obstacles you've encountered while teaching this subject? GUEST: One challenge is helping students grasp the complex regulatory landscape, but we've developed case studies and interactive sessions to make it more approachable. HOST: That's great to hear. Looking toward the future, how do you see the field of pediatric drug repurposing evolving? GUEST: I believe we'll see more public-private partnerships and increased collaboration between academia, industry, and regulatory agencies to advance pediatric drug development. HOST: Dr. Smith, thank you so much for joining us today and sharing your insights on the Certificate Programme in Drug Repurposing for Pediatric Conditions. We're excited to see the impact this course will have on the industry and the lives of children. GUEST: Thank you for having me. It's been a pleasure discussing this important topic with you.
